Walter Greenblatt & Associates, LLC serves as the Mergers & Acquisitions Department for publicly traded and private biotechnology and medical device companies seeking growth through acquisition but lacking the in-house resources to perform all the tasks critical to a successful program. We help the acquirer to develop the strategic framework needed to select appropriate candidates; to identify and approach prospective acquisition targets; to determine the value of the target; to negotiate an economically sound deal; to create—in advance—an integration plan; and to perform comprehensive due diligence.

Walter Greenblatt & Associates, LLC also compares the viable financing vehicles for your acquisition program and raises the required capital when necessary to implement the plan.

In short, we help ensure the success of your acquisition program.

Services for Acquiring Company
• Refine Acquisition Criteria to Match and Support Strategic Plan

• Identify Acquisition Candidates

• Value Candidate

• Design Deal Structure

• Negotiate Deal

• Evaluate Financing Options

• Raise Debt and Equity Capital

• Manage Due Diligence Process

• Close Purchase

Recent Mergers & Acquisitions Transactions:

Advanced BioHealing Acquires Dermagraft and Transcyte from Smith & Nephew (NYSE: SNN)